The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Dose-Dependency of Resveratrol in Providing Health Benefits
Open accessAbstract
This review describes the dose-dependent health benefits of resveratrol, a polyphenolic antioxidant that is found in a variety of foods, especially grape skin and red wine. Resveratrol provides diverse health benefits including cardioprotection, inhibition of low-density lipoprotein, activation of nitric oxide (NO) production, hindering of platelet aggregation [32] A.A.E. Bertelli, D.E. Giovannini, R.L. Caterina, W. Bernini, M. Migliori and M. Fregoni et al., Antiplatelet activity of cis-resveratrol, Drugs Exp Clin Res 22 (1996), pp. 61–63. View Record in Scopus | Cited By in Scopus (111) and promotion of antiinflammatory effects. Studies have shown that at a lower dose, resveratrol acts as an anti-apoptotic agent, providing cardioprotection as evidenced by increased expression in cell survival proteins, improved post-ischemic ventricular recovery and reduction of myocardial infarct size and cardiomyocyte apoptosis and maintains a stable redox environment compared to control. At higher dose, resveratrol acts as a pro-apoptotic compound, inducing apoptosis in cancer cells by exerting a death signal. At higher doses, resveratrol depresses cardiac function, elevates levels of apoptotic protein expressions, results in an unstable redox environment, increases myocardial infarct size and number of apoptotic cells. At high dose, resveratrol not only hinders tumor growth but also inhibits the synthesis of RNA, DNA and protein, causes structural chromosome aberrations, chromatin breaks, chromatin exchanges, weak aneuploidy, higher S-phase arrest, blocks cell proliferation, decreases wound healing, endothelial cell growth by fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor, and angiogenesis in healthy tissue cells leading to cell death. Thus, at lower dose, resveratrol can be very useful in maintaining the human health whereas at higher dose, resveratrol has pro-apoptotic actions on healthy cells, but can kill tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Pharmacological preconditioning with resveratrol: role of nitric oxide
Hattori, R., Otani, H., Maulik, N., & Das, D. K. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01012.2001 · Cited by 202
Self-citationRetractedDudley, J. I., Das, S., Mukherjee, S., & Das, D. K. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.05.003 · Cited by 117
Self-citationRetractedMukherjee, S., Lekli, I., Gurusamy, N., Bertelli, A. A. A., & Das, D. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.11.005 · Cited by 113
Self-citationRetractedDas, S., Fraga, C. G., & Das, D. K. (2006) · Free Radical Research · doi:10.1080/10715760600833085 · Cited by 112
Self-citationRetractedDudley, J. I., Lekli, I., Mukherjee, S., Das, M., Bertelli, A. A. A., & Das, D. K. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf801791d · Cited by 105
Self-citationRetractedMalik, G., Gorbounov, N., Das, S., Gurusamy, N., Otani, H., Maulik, N., Goswami, S. K., & Das, D. K. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2101 · Cited by 41
Self-citationRetractedArzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“Resveratrol has been shown to possess potential anticancer activity in various cancer cells at the initiation, promotion, and progression stages (Jang et al. 1997).”
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707 · cited 1×
“2006; Pearson et al. 2008; Lagouge et al. 2006; Milne et al. 2007).”
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., & Takada, Y. (2004) · PubMed · Cited by 1,395
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,165
Pearson, K. J., Baur, J. A., Lewis, K. N., Peshkin, L., Price, N. L., Labinskyy, N., Swindell, W. R., Kamara, D., Minor, R. K., Perez, E., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.011 · Cited by 1,162
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS
Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., et al. (2005) · Science · doi:10.1126/science.1117728 · Cited by 1,107 · cited 2×
“4 mg/kg/day) along with the high-fat diets extended the life span by inducing Sirt1 similar to calorierestricted animals with greater SIRT1 coexpression (Nisoli et al. 2005).”
InfluentialMechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065
Inhibition of human LDL oxidation by resveratrol
Frankel, E. N., Waterhouse, A. L., & Kinsella, J. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92472-6 · Cited by 887
Resveratrol: A molecule whose time has come? And gone?
Soleas, G. J., Diamandis, E. P., & Goldberg, D. M. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(96)00155-5 · Cited by 849
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 749
Substrate-specific activation of sirtuins by resveratrol
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500655200 · Cited by 745
Resveratrol: A review of preclinical studies for human cancer prevention
ATHAR, M., BACK, J., TANG, X., KIM, K., KOPELOVICH, L., BICKERS, D., & KIM, A. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.025 · Cited by 731
Xanthoudakis, S., & Curran, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05097.x · Cited by 708
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
Subbaramaiah, K., & Dannenberg, A. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00043-3 · Cited by 649
Evans, A. R., Limp-Foster, M., & Kelley, M. R. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00046-x · Cited by 532
Free radical-lipid interactions and their pathological consequences
Rice-Evans, C., & Burdon, R. (1993) · Progress in Lipid Research · doi:10.1016/0163-7827(93)90006-i · Cited by 514
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons
Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., & Néri, C. (2005) · Nature Genetics · doi:10.1038/ng1534 · Cited by 512
Resveratrol as an anticancer nutrient: molecular basis, open questions and promises
Signorelli, P., & Ghidoni, R. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.01.017 · Cited by 489
CO AS A CELLULAR SIGNALING MOLECULE
Kim, H. P., Ryter, S. W., & Choi, A. M. K. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141053 · Cited by 426
The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA
Wilson, D. M., & Barsky, D. (2001) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(01)00063-5 · Cited by 408
Bhardwaj, A., Sethi, G., Vadhan-Raj, Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-02-003988 · Cited by 395
Kopp, P. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380619 · Cited by 392
Guarente, L. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.024 · Cited by 371
Resveratrol: One molecule, many targets
Pirola, L., & Fröjdö, S. (2008) · IUBMB Life · doi:10.1002/iub.47 · Cited by 347
Frémont, L., Belguendouz, L., & Delpal, S. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00209-x · Cited by 333
Chan, J. Y., & Kwong, M. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00238-4 · Cited by 320
Resveratrol-Associated Renal Toxicity
Crowell, J. A. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh263 · Cited by 319
Klinge, C. M., Blankenship, K. A., Risinger, K. E., Bhatnagar, S., Noisin, E. L., Sumanasekera, W. K., Zhao, L., Brey, D. M., & Keynton, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411565200 · Cited by 296
The Daily Oral Administration of High Doses of trans-Resveratrol to Rats for 28 Days Is Not Harmful
Juan, M. E., Vinardell, M. P., & Planas, J. M. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.2.257 · Cited by 293
Thirunavukkarasu, M., Penumathsa, S. V., Koneru, S., Juhasz, B., Zhan, L., Otani, H., Bagchi, D., Das, D. K., & Maulik, N. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.004 · Cited by 271
Self-citationKundu, J. K., Shin, Y. K., Kim, S. H., & Surh, Y.-J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi349 · Cited by 271
Resveratrol in Cardioprotection: A Therapeutic Promise of Alternative Medicine
Das, D. K. (2006) · Molecular Interventions · doi:10.1124/mi.6.1.7 · Cited by 258
Self-citationARICHI, H., KIMURA, Y., OKUDA, H., BABA, K., KOZAWA, M., & ARICHI, S. (1982) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.30.1766 · Cited by 255
Isolation and Identification of Stilbenes in Two Varieties of Polygonumcuspidatum
Vastano, B. C., Chen, Y., Zhu, N., Ho, C.-T., Zhou, Z., & Rosen, R. T. (2000) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9909196 · Cited by 254
Park, C. E., Kim, M.-J., Lee, J. H., Min, B.-I., Bae, H., Choe, W., Kim, S.-S., & Ha, J. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.25 · Cited by 239
Yamazaki, I., & Piette, L. H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77389-4 · Cited by 235
Kinase Inhibitors from Polygonum cuspidatum
Jayatilake, G. S., Jayasuriya, H., Lee, E.-S., Koonchanok, N. M., Geahlen, R. L., Ashendel, C. L., McLaughlin, J. L., & Chang, C.-J. (1993) · Journal of Natural Products · doi:10.1021/np50100a021 · Cited by 233
Langlais, F., Kerboull, M., Sedel, L., & Ling, R. S. M. (2003) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.85b1.13948 · Cited by 225
Candelario-Jalil, E., de Oliveira, A. C. P., Gräf, S., Bhatia, H. S., Hüll, M., Muñoz, E., & Fiebich, B. L. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-25 · Cited by 223
Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells
Caddeo, C., Teskač, K., Sinico, C., & Kristl, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.024 · Cited by 218
The role of iron in oxygen radical mediated lipid peroxidation
Minotti, G., & Aust, S. D. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90087-2 · Cited by 216
Miyazaki, R., Ichiki, T., Hashimoto, T., Inanaga, K., Imayama, I., Sadoshima, J., & Sunagawa, K. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.166991 · Cited by 214
KAGA, S., ZHAN, L., MATSUMOTO, M., & MAULIK, N. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.08.003 · Cited by 199
The roles of polyphenols in cancer chemoprevention
Lee, K. W., & Lee, H. J. (2006) · BioFactors · doi:10.1002/biof.5520260202 · Cited by 186
Benitez, D. A., Pozo‐Guisado, E., Alvarez‐Barrientos, A., Fernandez‐Salguero, P. M., & Castellón, E. A. (2007) · Journal of Andrology · doi:10.2164/jandrol.106.000968 · Cited by 186
Potential Mechanism by Which Resveratrol, a Red Wine Constituent, Protects Neurons
ZHUANG, H., KIM, Y., KOEHLER, R. C., & DORÉ, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07534.x · Cited by 186
van Ginkel, P. R., Sareen, D., Subramanian, L., Walker, Q., Darjatmoko, S. R., Lindstrom, M. J., Kulkarni, A., Albert, D. M., & Polans, A. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0347 · Cited by 185
Orsini, F., Pelizzoni, F., Verotta, L., Aburjai, T., & Rogers, C. B. (1997) · Journal of Natural Products · doi:10.1021/np970069t · Cited by 174
Singh, N. P., Hegde, V. L., Hofseth, L. J., Nagarkatti, M., & Nagarkatti, P. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038984 · Cited by 173
HUANG, R.-P., & ADAMSON, E. D. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.265 · Cited by 166
GRUBER, J., TANG, S. Y., & HALLIWELL, B. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.059 · Cited by 163
The short-lived fish Nothobranchius furzeri as a new model system for aging studies
Tozzini, E. T., Valenzano, D. R., & Cellerino, A. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.039 · Cited by 162
Resveratrol suppresses prostate cancer progression in transgenic mice
Harper, C. E., Patel, B. B., Wang, J., Arabshahi, A., Eltoum, I. A., & Lamartiniere, C. A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm144 · Cited by 160
Hwang, J., KWAK, D. W., Sun, L., Kim, H. M., KIM, Y. M., & Park, O. J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.047 · Cited by 157
Sharma, S., Chopra, K., Kulkarni, S., & Agrewala, J. N. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03257.x · Cited by 154
Juan, S., Cheng, T., Lin, H., Chu, Y.-L., & Lee, W. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.015 · Cited by 153
Ferry‐Dumazet, H., Garnier, O., Mamani‐Matsuda, M., Vercauteren, J., Belloc, F., Billiard, C., Dupouy, M., Thiolat, D., Kolb, J. P., Marit, G., et al. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1327 · Cited by 152
Shen, M., Hsiao, G., Liu, C. L., Fong, T. H., Lin, K. H., Chou, D., & Sheu, J. R. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06788.x · Cited by 143
Paul, B., Masih, I. E., Deopujari, J. Y., & Charpentier, C. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(99)00044-6 · Cited by 142
Cadenas, S., & Barja, G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00019-2 · Cited by 139
Resveratrol as a new type of DNA-cleaving agent
Fukuhara, K., & Miyata, N. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00585-x · Cited by 139
Das, S., Cordis, G. A., Maulik, N., & Das, D. K. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00453.2004 · Cited by 133
Self-citationEl‐Mowafy, A. M., & White, R. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00541-4 · Cited by 132
Coordinated induction of iNOS–VEGF–KDR–eNOS after resveratrol consumption
Das, S., Alagappan, V. K. T., Bagchi, D., SHARMA, H. S., Maulik, N., & Das, D. K. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.02.013 · Cited by 131
Self-citationSzende, B., Tyihák, E., & Király-Véghely, Z. (2000) · Experimental & Molecular Medicine · doi:10.1038/emm.2000.16 · Cited by 131
Yen, G., Duh, P., & Lin, C.-W. (2003) · Free Radical Research · doi:10.1080/1071576031000083099 · Cited by 130
Fukuda, S., Kaga, S., Zhan, L., et al. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:1:043 · Cited by 129
Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice
Imamura, G., Bertelli, A. A. E., Bertelli, A., Otani, H., Maulik, N., & Das, D. K. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01013.2001 · Cited by 129
Self-citationDistribution of [3H]trans-resveratrol in rat tissues following oral administration
El-Mohsen, M. A., Bayele, H. K., Kuhnle, G., Gibson, G., Debnam, E. S., Srai, S. K., Rice-Evans, C. A., & Spencer, J. P. E. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061810 · Cited by 128
Xi, J., Wang, H., Mueller, R. A., Norfleet, E. A., & Xu, Z. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.024 · Cited by 123
Trincheri, N. F., Nicotra, G., Follo, C., Castino, R., & Isidoro, C. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl223 · Cited by 122
Bhat, K., & Pezzuto, J. M. (2001) · PubMed · Cited by 119
Stamler, J., Berkson, D. M., Lindberg, H. A., Hall, Y., Miller, W. A., Mojonnier, L., Levinson, M. J., Cohen, D. B., & Young, Q. D. (1966) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)33232-1 · Cited by 118
Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells
Cecchinato, V., Chiaramonte, R., Nizzardo, M., Cristofaro, B., Basile, A., Sherbet, G. V., & Comi, P. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.001 · Cited by 117
Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits
Wilson, T. E., Knight, T. J., Beitz, D. C., Lewis, D. S., & Engen, R. L. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00260-3 · Cited by 117
Toxicogenomics of resveratrol in rat liver
Hebbar, V., Shen, G., Hu, R., Kim, B.-R., Chen, C., Korytko, P. J., Crowell, J. A., LEVINE, B. S., & Kong, A.-N. T. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.039 · Cited by 115
Reduction and Release of Ferritin Iron By Plant Phenolics
Boyer, R. F., Clark, H. M., & LaRoche, A. P. (1988) · Journal of Inorganic Biochemistry · doi:10.1016/0162-0134(88)80025-4 · Cited by 114
Lekli, I., Szabó, G. V., Juhász, B., Das, S., Das, M., Varga, E., Szendrei, L., Gesztelyi, R., Váradi, J., Bak, I., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01048.2007 · Cited by 114
Self-citationIwasaki, K., MacKenzie, E. L., Hailemariam, K., Sakamoto, K., & Tsuji, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2845-2856.2006 · Cited by 112
Su, J.-L., Yang, C., Zhao, M., Kuo, M., & Yen, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702452200 · Cited by 110
trans‐Resveratrol Protects Embryonic Mesencephalic Cells from tert‐Butyl Hydroperoxide
Karlsson, J., Emgård, M., Brundin, P., & Burkitt, M. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750141.x · Cited by 109
Atten, M. J., Godoy-Romero, E., Attar, B. M., Milson, T., Zopel, M., & Holian, O. (2005) · Investigational New Drugs · doi:10.1007/s10637-005-5855-8 · Cited by 106
Doré, S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00805-5 · Cited by 101
Penumathsa, S. V., & Maulik, N. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-013 · Cited by 101
Involvement of c‐jun NH2‐terminal kinases in resveratrol‐induced activation of p53 and apoptosis
She, Q., Huang, C., Zhang, Y., & Dong, Z. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10041 · Cited by 97
Sun, C., Hu, Y., Liu, X., Wu, T., Wang, Y., He, W., & Wenning, W. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.06.016 · Cited by 92
Sirtuins: Novel targets for metabolic disease in drug development
Jiang, W. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.048 · Cited by 90
Ou, H., Chou, F., Sheen, H., Lin, T. M., Yang, C.-H., & Sheu, W. H. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.06.018 · Cited by 88
Stewart, J. R., & O’Brian, C. A. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000011787.75522.ec · Cited by 86
Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model
Busquets, S., Ametller, E., Fuster, G., Oliván, M., Raab, V., Argilés, J. M. A., & López-Soriano, F. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.035 · Cited by 81
Antioxidative and Prooxidative Action of Stilbene Derivatives
Miura, T., Muraoka, S., Ikeda, N., Watanabe, M., & Fujimoto, Y. (2000) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2000.d01-36.x · Cited by 77
Das, S., Tósaki, Á., Bagchi, D., Maulik, N., & Das, D. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095133 · Cited by 77
Self-citationKim, Y. A., Kim, G., Park, K.-Y., & Choi, Y. H. (2007) · Journal of Medicinal Food · doi:10.1089/jmf.2006.143 · Cited by 70
Sir2 mediates apoptosis through JNK-dependent pathways in Drosophila
Griswold, A. J., Chang, K. T., Runko, A. P., Knight, M. A., & Min, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803837105 · Cited by 69
Effect of resveratrol on some activities of isolated and in whole blood human neutrophils
Cavallaro, A., Ainis, T., Bottari, C. O., & Fimiani, V. (2003) · Physiological Research · doi:10.33549/physiolres.930364 · Cited by 63
Mnjoyan, Z. H., & Fujise, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.023 · Cited by 60
[Coronary risk factors. The French paradox].
Richard, J. L. (1987) · PubMed · Cited by 53
Sotomatsu, A., Nakano, M., & Hirai, S. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90651-e · Cited by 50
Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury
Gurusamy, N., Malik, G., Gorbunov, N. V., & Das, D. K. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.025 · Cited by 46
Self-citationAttenuation of Ischemia/Reperfusion Injury in Rats by the Anti-inflammatory Action of Resveratrol
Das, S., Falchi, M., Bertelli, A., Maulik, N., & Das, D. K. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296776 · Cited by 39
Self-citation[Long-term clinical results of the implantable automatic defibrillator].
Jf, L., Menasché, P., Laborde, F., Coumel, P., Piwnica, A. H., & Slama, R. (1987) · PubMed · Cited by 39
Resveratrol at High Doses Acts as an Apoptotic Inducer in Endothelial Cells
In, K., Park, J., & Park, H. (2006) · Cancer Research and Treatment · doi:10.4143/crt.2006.38.1.48 · Cited by 27
Dekkers, D. H. W., Bezstarosti, K., Gurusamy, N., Luijk, K., Verhoeven, A. J. M., Rijkers, E., Demmers, J., Lamers, J. M. J., Maulik, N., & Das, D. K. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00227.x · Cited by 27
Self-citationBertelli, A., Falchi, M., Dib, B., Pini, E., Mukherjee, S., & Das, D. K. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1926 · Cited by 25
Self-citationSato, M., Fraga, C. G., & Das, D. K. (2003) · Pathophysiology · doi:10.1016/j.pathophys.2003.10.005 · Cited by 20
Self-citation
Cited by
Resveratrol: A Double-Edged Sword in Health Benefits
Salehi, B., Mishra, A. P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P. V. T., Martins, N., & Sharifi-Rad, J. (2018) · Biomedicines · doi:10.3390/biomedicines6030091 · Cited by 1,129
Administration of resveratrol: What formulation solutions to bioavailability limitations?
Amri, A., Chaumeil, J. C., Sfar, S., & Charrueau, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.083 · Cited by 620
Plant flavonoids in cancer chemoprevention: role in genome stability
George, V. C., Dellaire, G., & Rupasinghe, H. P. V. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.11.007 · Cited by 362
Effect of resveratrol and pterostilbene on aging and longevity
Li, Y., Li, S., & Lin, C. (2018) · BioFactors · doi:10.1002/biof.1400 · Cited by 346
Health benefits of resveratrol administration
Galiniak, S., Aebisher, D., & Bartusik-Aebisher, D. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2018_2749 · Cited by 333
Metadata
- Authors
- Mukherjee, S., Dudley, J. I., & Das, D. K.
- Venue
- Dose-Response
- Publisher
- SAGE Publications
- Published
- 2010-03-19
- Volume
- 8
- Issue
- 4
- Pages
- 478-500
- ISSN
- 1559-3258 (ISSN-L)
- OpenAlex
- W2072826174
- Cited by
- 263
- References
- 118
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.